Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2011-0181

Trial Summary

About CDAS Project, PI, Publications: Insulin and Insulin-like Growth Factor Biomarkers and Prognosis of Prostate Cancer-specific Mortality

Datasets

Site: Prostate

Inclusion Criteria:

  • All I-Arm Males
  • No Rare Cancers
  • Adequate PSA
  • Prostate Cancer DX Before 09/T13
  • No Missing Damico Scores
  • Has Any Serum
  • Has Pre-DX Serum
  • Most Proximal Serum Draw to Dx is 0-7
  • Selected at a ratio of 600/total eligible controls in each cell

Matching Factors:

  • Prevalent/Incident Status
  • Damico Score

Match Ratio: 600/Total Eligible Controls in Each Cell

Match Technique: Case cohort with controls weighted to whole cohort

Additional Matching Comments: Match was done at a ratio of 600 (total desired controls)/total eligible controls in each cell. 8 cells made up of prevalent/incident and the 4 damico scores.

Analytes:

  • Adiponectin
  • C-Peptide
  • High-Molecular Weight Adiponectin
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor Binding Protein 3

Number of Cases: 115

Number of Controls: 628